等待开盘 08-14 09:30:00 美东时间
+1.710
+0.77%
This week's dividend activity included increased payouts from Wells Fargo (NYSE:WFC) and Clorox (CLX) as well as declarations from companies such as Visa (NYSE:V) and Occidental Petroleum (NYSE:OXY). ...
08-01 20:26
Insiders have been trading these 5 stocks: (($APPN)), (($TFC)), (($CTAS)), (($K...
07-26 21:02
今日重点评级关注:Craig-Hallum:维持DiaMedica Therapeutics"买入"评级,目标价从8美元升至11美元;花旗:维持Cogent Biosciences"买入"评级,目标价从15美元升至22美元
07-21 09:19
UBS analyst Joshua Chan maintains Cintas (NASDAQ:CTAS) with a Buy and raises the price target from $240 to $255.
07-19 02:18
Investors seek stability amid market volatility, focusing on companies that consistently outperform expectations and have solid fundamentals.
07-18 20:22
Top Wall Street analysts changed their outlook on these top names. For a comple...
07-18 20:06
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• **财务业绩**: - Cintas公司在2025财年第四季度实现总营收26.7亿美元,同比增长8%,其中有机增长为9%。 - 全年营收创下历史新高,达到103.4亿美元,同比增长7.7%,其中有机增长为8%。 - 第四季度稀释每股收益(EPS)为1.09美元,同比增长9%。全年稀释每股收益为4.40美元,同比增长16.1%。 - 全年运营利润率为22.8%,高于2024财年的21.6%。 - 第四季度毛利率为49.7%,高于2024财年同期的49.2%。全年毛利率增长9.1%。 - 2025财年自由现金流为16亿美元。</p
07-18 12:11
Cintas ( ($CTAS) ) has released its Q4 earnings. Here is a breakdown of the inf...
07-18 11:52
U.S. equities climbed on Thursday, with the S&P 500 briefly testing a record high 6,300 level at midday in New York, bolstered by strong earnings and upbeat retail sales data that reinforced investor risk appetite.
07-18 00:54
Cintas is trading higher after the company reported better-than-expected Q4 EPS...
07-18 00:27